Bridge Medicines

Accelerating drug discovery from academic research to human proof of concept

placeNew York City, New York, United States calendar_todayFounded 2016 groups4 employees language bridgemedicines.com

Registered entities

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Bank & private debt133%
Other / undisclosed133%
Coming soon